Test Price
2,800 AED✅ Home Collection Available
TIMM8A Gene Jensen Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TIMM8A لمتلازمة جنسن بتقنية التسلسل الجيني (NGS) في الإمارات | 2800 درهم | إرشادات هيئة الصحة بدبي 2026
Executive Summary
ملخص تنفيذي: اختبار جيني متطور للكشف عن الطفرات المسببة لمتلازمة جنسن (Mohr‑Tranebjaerg) باستخدام تقنية التسلسل الجيني الشامل (NGS)، مطابق لمعايير هيئة الصحة بدبي 2026. يتضمن استشارة وراثية متكاملة وسحب منزلي معتمد بدرجة حرارة متحكم بها.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection — VIP Mobile Phlebotomy 8 AM‑11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation included.
- Insurance: Direct Billing Verification — WhatsApp +971 54 548 8731.
Overview
The TIMM8A gene test utilises Next‑Generation Sequencing to detect pathogenic variants causing Jensen syndrome (Mohr‑Tranebjaerg syndrome), a rare X‑linked mitochondrial disorder characterised by sensorineural hearing loss, dystonia and optic atrophy. This comprehensive analysis covers all coding exons and flanking intronic regions, ensuring precise diagnosis and family planning guidance for UAE patients.
| Feature | Our Test (NGS) | Closest Alternative (Sanger) |
|---|---|---|
| Methodology | NGS with Sanger confirmation for all detected variants | Conventional Sanger sequencing of selected exons only |
| Coverage | Full TIMM8A gene – coding exons, splice sites, deep intronic hotspots | Limited to predetermined exons; may miss deep intronic or regulatory mutations |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
| Diagnostic Yield | >99.9% analytical sensitivity & specificity | ~95% for known point mutations; structural variants often missed |
Physician Insight & Safety Protocol
“As the supervising physician (DHA License 61713011), I emphasise that this genetic test must be interpreted within the full clinical context. A negative result does not exclude the diagnosis if clinical suspicion remains high, and a positive result requires multidisciplinary management. Every patient deserves compassionate counselling before and after testing.”
— Dr. PRABHAKAR REDDY, Consultant Neurologist & Clinical Geneticist
⚠ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & ER Red Flags
- Individuals unable to provide informed consent without a legally authorised guardian (minors must comply with CDS Law 2026 – parental consent & genetic counselling mandatory).
- Patient exhibits acute neurological emergency: sudden vision loss, dystonic storm, or new‑onset seizures — seek emergency care immediately; do not delay for genetic testing.
- Severe anaemia or contraindication to venipuncture; alternative sample collection (FTA card) must be arranged.
Patient FAQ & Clinical Guidance
What is the TIMM8A gene test for?
This genetic test identifies disease‑causing mutations in the TIMM8A gene linked to deafness‑dystonia‑optic neuropathy syndrome. It helps confirm a clinical diagnosis, guide treatment, and inform family members about inheritance risk.
يكشف هذا الاختبار الطفرات الجينية في جين TIMM8A المسببة لمتلازمة الصمم وخلل التوتر واعتلال العصب البصري.
How is the sample collected and what is the turnaround time?
A hospital‑grade phlebotomist visits your home (8 AM‑11 PM) to collect a blood sample using cold‑chain transport, or you may provide a DNA‑stabilised FTA card. Results are available within 3 to 4 weeks, with telephonic post‑test counselling included.
يتم سحب العينة منزلياً بواسطة أخصائي معتمد، وتظهر النتائج خلال 3 إلى 4 أسابيع مع استشارة هاتفية.
Is this test covered by insurance in the UAE?
Many UAE insurers honour direct billing for genetic testing when medically indicated; our team verifies your coverage via WhatsApp (+971 54 548 8731) before the. A valid physician referral is typically required.
تتحقق جهة الاتصال لدينا من تغطية التأمين عبر الواتساب قبل إجراء التحليل.
Full compliance with UAE Federal Decree‑Law No. 41 of 2024 (Art. 87 – Human Genome & Medical Data), Consumer Data Security Law 2026 (Minors), and UAE Personal Data Protection Law. Laboratory operations adhere to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA‑licensed genetic counselling provided prior to all tests.
ICD‑10‑CM codes associated with clinical indications: G31.8 (Other specified degenerative diseases of nervous system), H90.5 (Sensorineural hearing loss, unspecified), Z84.3 (Family history of other specific disorders).
LOINC code: 81247-1 (TIMM8A gene mutations found [Identifier] in Blood or Tissue by Sequencing).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians